Eli Lilly is dropping CVS Health's drug benefit plan for its employees after the healthcare conglomerate stopped covering the company's weight-loss drug in favor of Novo Nordisk's rival medication, ...

That said, the pharmacy giant still has a lot to do as it tries to fix parts of its business that still aren't performing as ...

CVS Health management raised 2025 EPS guidance, projecting robust double-digit earnings growth. Click here to read why CVS stock is a Buy.

Some customers might not be able to fill or pick up their prescriptions at CVS locations on Tuesday because of technical issues.A CVS spokesperson said in a statement Tuesday that the company is ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Investors are awaiting updates ...

Fintel reports that on October 24, 2025, UBS maintained coverage of CVS Health (NYSE:CVS) with a Buy recommendation. Analyst Price Forecast Suggests 1.99% Upside As of September 30, 2025, the average ...

(NEXSTAR) — While a system outage that impacted numerous CVS pharmacies has been resolved, according to a company spokesperson, it may still take you longer than expected to pick up your prescription ...

CVS Health rode double-digit sales growth from drugstores and its pharmacy benefits management business to a better-than-expected third quarter. The health care giant also hiked its 2025 forecast ...